AGER and non-small cell lung carcinoma: In NSCLC cells, siRNA-suppressed RAGE inhibits PI3K/AKT activity, impacts downstream mTOR/p70S6K signaling, and reduces the phosphorylation initiation of KRAS and RAF-1 at the same time.